Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center

PURPOSE: Treatment of breast cancer (BC) with borderline or low (1%-9%) estrogen and progesterone expression remains controversial, with recent data disputing ASCO/College of American Pathologists 2010 guidelines that lowered the threshold of receptor positivity from 10% to 1%. The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreidieh, Firas, Sadek, Ramses F., Zhang, Li Fang, Gopal, Aaron, Blaize, Jean-Pierre, Yashar, David, Patel, Reena, Patel, Hiral S., Tang, Shou-Ching, Abdul Sater, Houssein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974571/
https://www.ncbi.nlm.nih.gov/pubmed/35201853
http://dx.doi.org/10.1200/PO.21.00201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974571/
https://www.ncbi.nlm.nih.gov/pubmed/35201853
http://dx.doi.org/10.1200/PO.21.00201

Ejemplares similares